Status:
COMPLETED
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
Lead Sponsor:
CAMC Health System
Conditions:
Kidney Stones
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators main hypothesis is that the stone free rate will be much higher (95%) in patients treated with PCNL than patients treated with ESWL where stone free rate is (60%) to determine which ...
Detailed Description
Extracorporeal shock wave lithotripsy is preferred for small stones less than 10 mm in size. Percutaneous nephrolithotomy is the standard therapy used for large kidney stones greater than 20 millimete...
Eligibility Criteria
Inclusion
- Patients of both sex with age greater than 18 years to 90 years
- Stone burden between 10 and 20 mm diagnosed by CT scan
- Patient must be agreeable to randomization between shock wave lithotripsy and percutaneous stone removal
Exclusion
- Patients with bleeding diathesis or taking anti-platelet or anti-coagulant medication
- Patients who are pregnant based on routine pre-operative pregnancy testing
- Patients with skin to stone size greater than 12 cm (measured routinely on CT scan)
- Patients with either Horseshoe kidney, transplant kidney or a solitary kidney
- Patients with ureteral calculi
- Patients with stone size of \< 10 mm and \> 20 mm
- Ureteropelvic junction obstruction
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00873054
Start Date
October 1 2008
End Date
January 1 2011
Last Update
February 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology Center of Charleston
Charleston, West Virginia, United States, 25301